UWC Qualitative Evidence Synthesis protocol development short course
The School of Public Health at the University of the Western Cape will be hosting a Qualitative Evidence Synthesis protocol development short course from 5 October - 7 November 2022.
Surgery on both eyes on the same day or on different days: which works better to treat cataract in both eyes?
Age-related cataract affects both eyes in most cases. Most people undergo cataract surgery in both eyes on separate days, referred to as delayed sequential bilateral cataract surgery (DSBCS). An alternative procedure involves operating on both eyes on the same day, but as two separate procedures, known as immediate sequential bilateral cataract surgery (ISBCS). Potential advantages of ISBCS include fewer hospital visits for the patient, faster visual recovery, and lower healthcare costs.
Cochrane Library Editorial: Low sodium salt substitutes
A new Cochrane Library editorial: Low sodium salt substitutes - a tool for sodium reduction and cardiovascular health.
Running shoes for preventing lower-limb running injuries in adults
Lower‐limb running injuries are common. Running shoes have been proposed as one means of reducing injury risk. However, there is uncertainty as to how effective running shoes are for the prevention of injury. It is also unclear how the effects of different characteristics of running shoes prevent injury. Key messages
Cochrane SA seeks Communications Officer for the GELA project
GELA Communications Officer (Part-time 1 day a week) Duration: 1 year with the possibility to extend up to the duration of the project Closing date: 5 September 2022
2021 Journal Impact Factor for Cochrane Database of Systematic Reviews is 12.008
The 2021 Journal Citation Report has been released by Clarivate Analytics, and we are delighted to announce that the Journal Impact Factor for the Cochrane Database of Systematic Reviews (CD
Cochrane SA is offering bursaries for the Primer in Systematic Reviews Course
Cochrane South Africa is offering bursaries to attend the Stellenbosch University Primer in Systematic Reviews course. The course takes place from 1 September - 31 October 2022.
Is ivermectin effective for COVID-19?
What is ivermectin? Ivermectin is a medicine used to treat parasites, such as intestinal parasites in animals, and scabies in humans. It is inexpensive and is widely used in regions of the world where parasitic infestations are common. It has few unwanted effects. Medical regulators have not approved ivermectin for COVID‐19.
Interventions to reduce the risk of SARS-CoV-2 infection among workers outside healthcare settings
Coronavirus (COVID‐19) is a respiratory infectious disease that has spread globally. People infected with SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) can develop critical illnesses and may die, particularly older people, and those with underlying medical problems. Different interventions that attempt to prevent or reduce workers' exposure to SARS-CoV-2 in the workplace have been implemented during the pandemic.
Cochrane releases RevMan Web software for non-Cochrane systematic reviews
Cochrane is delighted to announce the availability for the first time of RevMan Web, its popular, web-based systematic-review production software, to the wider community beyond Cochrane – to support evidence synthesis development and evidence-based medicine education.